GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients

This publication has 35 references indexed in Scilit:

• Lack of effect of mood stabilizers or neuroleptics on GSK-3 protein levels and GSK-3 activity
  International Journal of Neuropsychopharmacology, 2003
• Glycogen Synthase Kinase-3β
  Circulation Research, 2002
• Glycogen synthase kinase-3β immunoreactivity is reduced in the prefrontal cortex in schizophrenia
  Neuroscience Letters, 2001
• Emerging principles of altered neural circuitry in schizophrenia
  Brain Research Reviews, 2000
• MECHANISMS OF WNT SIGNALING IN DEVELOPMENT
  Annual Review of Cell and Developmental Biology, 1998
• WNT-1 and HGF Regulate GSK3β Activity and β-Catenin Signaling in Mammary Epithelial Cells
  Biochemical and Biophysical Research Communications, 1998
• Confirmation of the Diagnosis of Schizophrenia after Death Using DSM-IV: A Victorian Experience
  Australian & New Zealand Journal of Psychiatry, 1998
• Do obstetric complications cause the earlier age at onset in male than female schizophrenics?
  Schizophrenia Research, 1996
• Relations between neuropsychological performance and brain morphological and physiological measures in monozygotic twins discordant for schizophrenia
  Psychiatry Research: Neuroimaging, 1994
• Low birth weight and a family history of schizophrenia predict poor premorbid functioning in psychosis
  Schizophrenia Research, 1991